Auteurs
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Masaaki Mori »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Masaaki Ito < Masaaki Mori < Masaaki Nakano  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000037 (2020) Masaki Shimizu [Japon] ; Mao Mizuta [Japon] ; Nami Okamoto [Japon] ; Takahiro Yasumi [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Yuka Okura [Japon] ; Noriko Kinjo [Japon] ; Tomohiro Kubota [Japon] ; Yasuo Nakagishi [Japon] ; Kenichi Nishimura [Japon] ; Mariko Mohri [Japon] ; Masato Yashiro [Japon] ; Junko Yasumura [Japon] ; Hiroyuki Wakiguchi [Japon] ; Masaaki Mori [Japon]Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
001053 (2015) Shumpei Yokota [Japon] ; Masako Kikuchi ; Tomo Nozawa ; Taichi Kanetaka ; Tomomi Sato ; Kazuko Yamazaki ; Nodoka Sakurai ; Ryoki Hara ; Masaaki MoriPathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome".
001328 (2014) Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoLongterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
001385 (2014) Chie Aoki ; Yutaka Inaba [Japon] ; Hyonmin Choe ; Utako Kaneko ; Ryoki Hara ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Mari S. Oba ; Shumpei Yokota ; Tomoyuki SaitoDiscrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.
001535 (2013) Yutaka Inaba [Japon] ; Remi Ozawa ; Chie Aoki ; Tomoyuki Imagawa ; Masaaki Mori ; Ryoki Hara ; Takako Miyamae ; Tomoyuki Saito ; Shumpei YokotaRadiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis.
001559 (2013) Shumpei Yokota ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoLong-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan.
001712 (2012) Toshihiko Shinoki [Japon] ; Ryoki Hara ; Utako Kaneko ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Shumpei YokotaSafety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab.
001713 (2012) Tomoyuki Imagawa [Japon] ; Shumpei Yokota ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Hiroyuki Imanaka ; Yasuhito Nerome ; Naomi Iwata ; Takuji Murata ; Mari Miyoshi ; Norihiro Nishimoto ; Tadamitsu KishimotoSafety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis.
001869 (2011) Yutaka Inaba ; Remi Ozawa ; Tomoyuki Imagawa ; Masaaki Mori ; Yoshinori Hara ; Takako Miyamae ; Chie Aoki ; Tomoyuki Saito ; Shumpei YokotaRadiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment.
001907 (2011) Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Syuji Takei ; Takuji Murata ; Minako Tomiita ; Yasuhiko Itoh ; Satoshi Fujikawa ; Masaaki MoriGuidance on using tocilizumab for juvenile idiopathic arthritis.
001A97 (2009) Shoko Nakajima [Japon] ; Takuya Naruto ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Shigeru Nishimaki ; Shumpei YokotaInterleukin-6 inhibits early differentiation of ATDC5 chondrogenic progenitor cells.
001B00 (2009) Shoko Nakajima [Japon] ; Takuya Naruto ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Shigeru Nishimaki ; Shumpei YokotaImprovement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab.
001B61 (2008) Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Yukoh Aihara ; Shuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoEfficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.
001C27 (2005) Shumpei Yokota [Japon] ; Takako Miyamae ; Tomoyuki Imagawa ; Shigeki Katakura ; Rumiko Kurosawa ; Masaaki MoriClinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Masaaki Mori" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Masaaki Mori" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Masaaki Mori
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021